Global MedTech Media InstituteSwitzerlandProfessional healthcare technology intelligence
Editor profile
Thomas Müller
Editor, Medical Devices & Hardware
Thomas Müller reports on developments in medical hardware, from robotic surgical systems to high-tech wearables. He tracks the global supply chain of critical diagnostic equipment.
The U.S. FDA has announced that Dexcom is the first participant in its TEMPO Digital Health Pilot Program, which allows certain digital health devices to be exempt from premarket review while collecting real-world data through Medicare. Dexcom plans to use AI and continuous glucose monitoring technology to screen for prediabetes and type 2 diabetes, marking a deep integration of regulatory innovation and payment reform.
A joint survey by the American Medical Association (AMA) and Medscape shows that 97% of physicians at least occasionally review patient wearable device data, but fewer than 6% integrate it into clinical workflows. The lack of payment pathways, insufficient electronic health record integration, and concerns about legal liability and reliability are key barriers.
XRHealth acquires digital therapeutics company Swing Therapeutics, integrating the FDA De Novo-authorized Stanza fibromyalgia treatment with its virtual clinic to build a cross-device XR chronic pain management platform, and achieving comprehensive reimbursement through Medicare and commercial insurance.
After withdrawing from the most-favored-nation clause, Danish pharmaceutical procurement agency Amgros has filed a multi-million dollar claim against Amgen. Both parties have hired lawyers, and the case may go to court. This incident reflects the deep contradictions in global drug pricing and healthcare policy.
Discuss the impact of AI on employment in the healthcare industry, analyzing which positions are at risk, which are safe, and the new opportunities created by AI.
Australian Melbourne-based startup Everlab has completed a $46 million Series A funding round, and plans to use its AI-driven preventive healthcare platform to expand into overseas markets such as the UK.
In 2026, Hybrid Care 2.0 integrates AI telemedicine, continuous monitoring, intelligent triage, and predictive analytics into a responsive patient experience, shifting from reactive treatment to proactive prevention. This article analyzes its industry background, key developments, market impact, and future challenges.
Latest industry discussions around Telemedicine, virtual care, and medical collaboration analyze why telemedicine is shifting from a point-of-care consultation tool to cross-institution collaborative infrastructure, and what this means for Digital Health, AI Healthcare, and the restructuring of healthcare institution workflows.